Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Catholic University of the Sacred Heart
With
Merck Sharp & Dohme LLC
Age
6–14
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Children 6 to 14 yrs old, step 1 and step 2 GINA (Global INitiative for Asthma) guidelines
exhaled nitric oxide (NO) \>20 PPB at visit 2
symptoms more often than twice a day, FEV1 equal or higher than 80% of predicted value and reversibility equal or higher than 12% to salbutamol, or a positive provocation test with methacholine, or exercise
no regular medication, inhaled short-acting beta-2 agonists for symptom relief
You may not be if
Patient is hospitalized
Patient has FEV1 \< 80% predicted on visit 1
Patient has 2 or more nighttime awakenings for asthma per week or pef variability 30% or more
upper respiratory infection in the previous 3 weeks
treatment with glucocorticoids or LTRAs in the previous 4 weeks
treatment with inhaled glucocorticoids for more than 4 weeks in the previous year
Clareo Health | Effects of Montelukast in Children With Asthma
